BRIDGEWAY CAPITAL MANAGEMENT, LLC - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 24 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q3 2018$146,000
-5.2%
13,9000.0%0.00%
-50.0%
Q2 2018$154,000
-22.2%
13,900
-44.0%
0.00%0.0%
Q1 2018$198,000
-69.9%
24,800
-69.0%
0.00%
-71.4%
Q4 2017$657,000
+32.2%
80,1000.0%0.01%
+16.7%
Q3 2017$497,000
-16.5%
80,100
-18.5%
0.01%
-14.3%
Q2 2017$595,000
+14.2%
98,3000.0%0.01%
+16.7%
Q1 2017$521,000
-28.7%
98,300
-8.6%
0.01%
-40.0%
Q4 2016$731,000
-7.7%
107,5000.0%0.01%
-16.7%
Q3 2016$792,000
-10.0%
107,5000.0%0.01%
-14.3%
Q2 2016$880,000
+36.6%
107,5000.0%0.01%
+27.3%
Q1 2016$644,000
+12.4%
107,5000.0%0.01%0.0%
Q4 2015$573,000
+32.0%
107,5000.0%0.01%
+22.2%
Q3 2015$434,000
-17.8%
107,5000.0%0.01%
-10.0%
Q2 2015$528,000
+23.9%
107,5000.0%0.01%
+11.1%
Q1 2015$426,000
+1.7%
107,5000.0%0.01%
-10.0%
Q4 2014$419,000107,5000.01%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Penbrook Management LLC 344,060$1,634,0001.26%
Union Square Park Capital Management, LLC 400,000$1,900,0000.76%
P.A.W. CAPITAL CORP 100,000$475,0000.42%
PRECEPT MANAGEMENT LLC 150,000$713,0000.29%
Newbridge Financial Services Group, Inc. 73,500$349,0000.29%
SANDERS MORRIS HARRIS LLC 183,584$990,0000.22%
FRIESS ASSOCIATES LLC 555,000$2,636,0000.19%
PERRITT CAPITAL MANAGEMENT INC 30,651$146,0000.09%
Ikarian Capital, LLC 219,109$1,041,0000.05%
SEGALL BRYANT & HAMILL, LLC 705,823$3,352,0000.04%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders